Joseph France
Stock Analyst at Cantor Fitzgerald
(2.66)
# 1,961
Out of 5,154 analysts
55
Total ratings
65.71%
Success rate
10.74%
Average return
Main Sectors:
Stocks Rated by Joseph France
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $83 → $85 | $25.62 | +231.77% | 7 | Sep 14, 2023 | |
| HCA HCA Healthcare | Maintains: Buy | $285 → $320 | $532.81 | -39.94% | 3 | Apr 24, 2023 | |
| ELV Elevance Health | Maintains: Buy | $565 → $550 | $289.64 | +89.89% | 1 | Apr 21, 2023 | |
| UNH UnitedHealth Group | Maintains: Buy | $590 → $600 | $286.48 | +109.44% | 4 | Apr 17, 2023 | |
| CCRN Cross Country Healthcare | Initiates: Buy | $30 | $9.82 | +205.50% | 9 | Mar 10, 2023 | |
| CVS CVS Health | Initiates: Buy | $120 | $77.92 | +54.00% | 2 | Jun 17, 2022 | |
| THC Tenet Healthcare | Initiates: Buy | $80 | $236.95 | -66.24% | 2 | Jun 17, 2022 | |
| UHS Universal Health Services | Initiates: Hold | $115 | $192.65 | -40.31% | 3 | Jun 17, 2022 | |
| CI The Cigna Group | Initiates: Hold | $270 | $271.63 | -0.60% | 2 | Jun 17, 2022 | |
| MOH Molina Healthcare | Initiates: Hold | $310 | $144.47 | +114.58% | 1 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5 | $3.35 | +49.25% | 2 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $510 | $179.15 | +184.68% | 3 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $43.65 | +129.10% | 2 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $50 | $207.23 | -75.87% | 3 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $103 → $107 | $81.09 | +31.95% | 3 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $10 | $2.19 | +356.62% | 2 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $103.21 | -25.39% | 1 | Sep 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $46 | $38.40 | +19.79% | 1 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $80 | $84.62 | -5.46% | 1 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $34 | $47.69 | -28.71% | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $21 | $17.28 | +21.53% | 1 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $7 | $22.61 | -69.04% | 1 | Jul 6, 2017 |
Acadia Healthcare Company
Sep 14, 2023
Maintains: Neutral
Price Target: $83 → $85
Current: $25.62
Upside: +231.77%
HCA Healthcare
Apr 24, 2023
Maintains: Buy
Price Target: $285 → $320
Current: $532.81
Upside: -39.94%
Elevance Health
Apr 21, 2023
Maintains: Buy
Price Target: $565 → $550
Current: $289.64
Upside: +89.89%
UnitedHealth Group
Apr 17, 2023
Maintains: Buy
Price Target: $590 → $600
Current: $286.48
Upside: +109.44%
Cross Country Healthcare
Mar 10, 2023
Initiates: Buy
Price Target: $30
Current: $9.82
Upside: +205.50%
CVS Health
Jun 17, 2022
Initiates: Buy
Price Target: $120
Current: $77.92
Upside: +54.00%
Tenet Healthcare
Jun 17, 2022
Initiates: Buy
Price Target: $80
Current: $236.95
Upside: -66.24%
Universal Health Services
Jun 17, 2022
Initiates: Hold
Price Target: $115
Current: $192.65
Upside: -40.31%
The Cigna Group
Jun 17, 2022
Initiates: Hold
Price Target: $270
Current: $271.63
Upside: -0.60%
Molina Healthcare
Jun 17, 2022
Initiates: Hold
Price Target: $310
Current: $144.47
Upside: +114.58%
Jun 17, 2022
Initiates: Hold
Price Target: $5
Current: $3.35
Upside: +49.25%
Jun 17, 2022
Initiates: Buy
Price Target: $510
Current: $179.15
Upside: +184.68%
Jun 17, 2022
Initiates: Buy
Price Target: $100
Current: $43.65
Upside: +129.10%
Nov 2, 2018
Maintains: Overweight
Price Target: $42 → $50
Current: $207.23
Upside: -75.87%
Nov 2, 2018
Maintains: Neutral
Price Target: $103 → $107
Current: $81.09
Upside: +31.95%
Sep 28, 2018
Downgrades: Neutral
Price Target: $12 → $10
Current: $2.19
Upside: +356.62%
Sep 13, 2018
Initiates: Overweight
Price Target: $77
Current: $103.21
Upside: -25.39%
Aug 10, 2018
Maintains: Overweight
Price Target: $45 → $46
Current: $38.40
Upside: +19.79%
Aug 8, 2018
Maintains: Neutral
Price Target: $75 → $80
Current: $84.62
Upside: -5.46%
Dec 21, 2017
Initiates: Overweight
Price Target: $34
Current: $47.69
Upside: -28.71%
Nov 7, 2017
Maintains: Overweight
Price Target: $20 → $21
Current: $17.28
Upside: +21.53%
Jul 6, 2017
Initiates: Overweight
Price Target: $7
Current: $22.61
Upside: -69.04%